Articles

Lilly stock shrugs off analyst downgrade

The drugmaker has become too reliant on its remaining pipeline of drugs under development for growth as it deals with patent expirations to big sellers and drug-development setbacks, a Jefferies analyst wrote.

Read More

City officials aim to build on momentum for cycling

Indianapolis has become a more bike-friendly city, and city planners are looking to ensure the progress continues. The Metropolitan Development Commission will vote Oct. 16 on a bicycle master plan that lays out a host of educational and policy initiatives to encourage two-wheeled transportation.

Read More

Gene Glick was a soldier, a builder and a philanthropic giant

Gene Biccard Glick, who died at home following a long battle with Alzheimer’s disease, built affordable housing sprawling across 10 states—a business empire that paved the way for tens of millions of dollars in donations to causes ranging from medicine to recreation.

Read More

Lilly to buy back $5B as sales goal harder to reach

Eli Lilly and Co. said Thursday that meeting its sale target will be a challenge. It plans to repurchase $5 billion in shares and introduce new diabetes drugs to help navigate through patent losses. Another immediate hurdle: Obamacare.

Read More

THOMAS: Confusion about health care act abounds

As president of a professional employer organization, I spend an enormous amount of time dealing with the complexities of the Affordable Care Act from the perspective of an employer sponsoring a health insurance plan.

Read More

BURNS: Music therapy hits the high notes

It’s a common and natural occurrence: A song comes on the radio and you instantly recall memories—perhaps it makes you smile or remember old friends, or it just takes you back to a moment in your life.

Read More